Left Ventricular Support with the Impella® LP 5.0 for Cardiogenic Shock Following Cardiac Surgery

Rossiter-Thornton, Michael; Viswanath, Arun; Forrest, A. Paul; Bayfield, Matthew S.; Wilson, Michael K.

doi:10.1016/j.hlc.2008.02.003

Cited by 25 publications

(12 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this case the Impella left ventricular assistance appears helped left ventricular recovery within 24 hours of implantation while left ventricular function usually takes 7-10 days before it returns to normal [15]. Impella device has been successfully used in the settings of cardiogenic shock associated with acute myocardial infarction and High risk percutaneous coronary interventions [16][17][18], as a bridge to heart transplant [19], facilitated pos-operaative recovery following coronary artery by pass surgery [20], fulminant acute myocarditis [21] and balloon aortic valvuloplasty in a high-risk patient [22].…”

Section: Discussionmentioning

confidence: 99%

Use of the Impella Left Ventricular Assist Device as a Bridge to Recovery in a Patient with Cardiogenic Shock Related to Takotsubo Cardiomyopathy

Hamid¹,

Eichhöfer²,

Fraser³

et al. 2013

J Clin Exp Cardiolog

View full text Add to dashboard Cite

The Impella Recover LP 2.5 ® (Abiomed Inc, Danvers, Massachusetts, USA) is an effective and minimally invasive left ventricular assist device and a useful tool in the treatment of patients undergoing high risk percutaneous coronary interventions and critically ill patients with poor left ventricular function. We present the use of the revised Impella Recover LP 2.5 ® left ventricular assist device, in a patient with acute heart failure and cardiogenic shock secondary to severe Takotsubo cardiomyopathy. The revised Impella Recover LP 2.5 ® left ventricular assist device is able to provide cardiac output of up to 2.5 l/min. The patient was weaned off the Impella device in 48 hours and was discharged on day 6 of admission without sequelae.

show abstract

Section: Discussionmentioning

confidence: 99%

Use of the Impella Left Ventricular Assist Device as a Bridge to Recovery in a Patient with Cardiogenic Shock Related to Takotsubo Cardiomyopathy

Hamid¹,

Eichhöfer²,

Fraser³

et al. 2013

J Clin Exp Cardiolog

View full text Add to dashboard Cite

show abstract

“…Reported complications associated with the Impella device include sensor failure, pump displacement, hemolysis, functional mitral stenosis, and femoral artery thrombosis 2‐4 . It has been used in patients with acute deterioration of a dilated cardiomyopathy, in acute heart failure after myocardial infarction and viral myocarditis 5 as well as for circulatory support after coronary artery bypass grafting 6,7 …”

Section: Commentsmentioning

confidence: 99%